MR Imaging of Lung in the Follow-up Assessment of Cystic Fibrosis
NCT: NCT03357562 · COMPLETED
NCT IDNCT03357562
StatusCOMPLETED
Start Date2018-05-05
Completion2025-03-06
Brief Summary
The aim of the study is to assess the diagnostic sensitivity of MRI to detect changes in Helbich-Bhalla scoring over time in patients with cystic fibrosis
Frequently Asked Questions
What is MR Imaging of Lung in the Follow-up Assessment of Cystic Fibrosis?
MR Imaging of Lung in the Follow-up Assessment of Cystic Fibrosis is a clinical trial registered under NCT03357562. Current status: COMPLETED.
What is the status of NCT03357562?
The current status of NCT03357562 (MR Imaging of Lung in the Follow-up Assessment of Cystic Fibrosis) is: COMPLETED.
When did MR Imaging of Lung in the Follow-up Assessment of Cystic Fibrosis start?
MR Imaging of Lung in the Follow-up Assessment of Cystic Fibrosis started on 2018-05-05.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.